Searched for
EUROPEAN REGULATORY APPROVAL
Europe is finally, slowly getting its act togetherEurope stands on the brink of a pivotal transformation, launching a set of ambitious reforms aimed at revitalizing its economy and global f...- Elon Musk's Starlink India launch hits security roadblock ahead of SpaceX IPOIndia has halted approvals for Elon Musk's Starlink internet service. Security agencies are concerned about Starlink terminals being used i...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- From Siri AI to child safety tools: Key takeaways from Apple's WWDCApple introduced Siri AI, a new AI-powered personal assistant integrated with Apple Intelligence capabilities that can understand personal ...
- Apple WWDC 2026 event keynote, highlights: New AI Siri, Apps to photo editing - details hereApple introduced Siri AI, a new AI-powered personal assistant integrated with Apple Intelligence capabilities that can understand personal ...
- WWDC 2026: Siri AI, Apple Intelligence, child safety tools and more — Biggest announcements from AppleApple has announced its biggest AI advancements at WWDC 2026. A completely redesigned Siri will understand context and perform actions acro...
- SpaceX IPO: How to buy shares in Elon Musk company? Full list of countries from which international investors can buy stocksHow to buy SpaceX IPO: Trading under the symbol SPCX, SpaceX has picked a handful of brokerage firms to distribute shares in the IPO to ret...
- Root cause: India’s spice crown under threat as quality concerns trace back to farmsFarm-level traceability, quality, value addition, and branding are key to converting export scale into global trust, according to experts.
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- Suzlon seeks to put the wind in all sails of its renewables shipSuzlon is set to significantly expand its renewable energy business. The company aims to quadruple annual sales to 10 GW and grow managed a...
- New tariff: Think tank GTRI makes a case against US' additional 12.5% duty on IndiaAs India faces a proposed 12.5% US tariff on its imports, trade think tank GTRI has advised the govt to challenge the levy on legal grounds...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Crypto companies without EU licences face prosecution, French regulator warnsCrypto firms face a June 30 deadline to secure European Union licenses. France's top markets regulator, AMF, warns that non-compliant compa...
- Tata Steel shares crack 4% after Q4 results. Here's why JPMorgan downgraded the stockTata Steel's shares dipped despite a 147% surge in Q4 FY26 net profit to Rs 2,965 crore. Analysts are divided, with JPMorgan downgrading to...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- India spots an export champion in a sector tariffs failed to sinkIndia's seafood sector has demonstrated remarkable resilience, transforming a 50% US tariff into a catalyst for growth. Through strategic m...
- I-Beauty! After J, K and C, now it's India's turn in the big beautiful marketIndia's beauty industry is emerging as a global force, blending Ayurvedic heritage with modern science to create "I-beauty." With rising ex...
- One trip, one ticket: New EU rules aim to ease train travelThe EU plans to force railway companies to sell rivals' tickets on their websites and share data with booking platforms, under new rules un...
- Curb your overenthusiasm: Why India must avoid early overregulation while drafting rules for new techIndia faces a critical choice in regulating new industries like AI and genomics. Overly cautious, ex-ante regulations, similar to the histo...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
Load More
